Vimarsana
Biggest News Aggregation in the World

Page 18 - Libby Holman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Libby Holman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Libby Holman Today - Breaking & Trending Today

New Alzheimer's Drug Is Off to Slow Start – NBC10 Philadelphia - Vimarsana News

New Alzheimer's Drug Is Off to Slow Start – NBC10 Philadelphia

The first drug to show that it slows Alzheimer’s is on sale, but treatment for most patients is still several months away. Two big factors behind the slow...

Why a new Alzheimer's drug is having a slow US debut – Metro US - Vimarsana News

Why a new Alzheimer's drug is having a slow US debut – Metro US

<div class="at-above-post addthis_tool" data-url="http://www.metro.us/why-a-new-alzheimers-drug-is-having-a-slow-us-debut/"></div>The first drug to show that it slows Alzheimer’s is on sale, but treatment for most patients is still several months away. Two big factors behind the slow debut, experts say, are scant insurance coverage and a long setup time needed by many health systems. Patients who surmount those challenges will step to the head […]<!-- AddThis Advanced Settings above via filter on get_the_excerpt --><!-- AddThis Advanced Setting...

Source: metro.us
Why a new Alzheimer's drug is having a slow U.S. debut - Vimarsana News

Why a new Alzheimer's drug is having a slow U.S. debut

Many health systems require a long setup time, the cost is high, and there are currently few options outside self-pay.

Why a new Alzheimer's drug is having a slow U.S. debut - Vimarsana News

Why a new Alzheimer's drug is having a slow U.S. debut

The first drug to show that it slows Alzheimer's is on sale, but treatment for most patients is still several months away.

Why a new Alzheimer's drug is having a slow US debut - Vimarsana News

Why a new Alzheimer's drug is having a slow US debut

The first drug to show that it slows Alzheimer’s is on sale, but treatment for most patients is still several months away.